These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23788275)

  • 1. Spindle assembly checkpoint gene expression in childhood adrenocortical tumors (ACT): Overexpression of Aurora kinases A and B is associated with a poor prognosis.
    Borges KS; Moreno DA; Martinelli CE; Antonini SR; de Castro M; Tucci S; Neder L; Ramalho LN; Seidinger AL; Cardinalli I; Mastellaro MJ; Yunes JA; Brandalise SR; Tone LG; Scrideli CA
    Pediatr Blood Cancer; 2013 Nov; 60(11):1809-16. PubMed ID: 23788275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia.
    Lucena-Araujo AR; de Oliveira FM; Leite-Cueva SD; dos Santos GA; Falcao RP; Rego EM
    Leuk Res; 2011 Feb; 35(2):260-4. PubMed ID: 20732714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.
    Arai E; Gotoh M; Tian Y; Sakamoto H; Ono M; Matsuda A; Takahashi Y; Miyata S; Totsuka H; Chiku S; Komiyama M; Fujimoto H; Matsumoto K; Yamada T; Yoshida T; Kanai Y
    Int J Cancer; 2015 Dec; 137(11):2589-606. PubMed ID: 26061684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BubR1 and AURKB overexpression are associated with a favorable prognosis in gastric cancer.
    Enjoji M; Iida S; Sugita H; Ishikawa T; Uetake H; Inokuchi M; Yamada H; Kojima K; Sugihara K
    Mol Med Rep; 2009; 2(4):589-96. PubMed ID: 21475871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT).
    Leite FA; Lira RC; Fedatto PF; Antonini SR; Martinelli CE; de Castro M; Neder L; Ramalho LN; Tucci S; Mastelaro MJ; Seidinger AL; Cardinalli IA; Yunes JA; Brandalise SR; Tone LG; Scrideli CA
    Pediatr Blood Cancer; 2014 Nov; 61(11):1940-8. PubMed ID: 25156210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spindle assembly checkpoint protein expression correlates with cellular proliferation and shorter time to recurrence in ovarian cancer.
    McGrogan B; Phelan S; Fitzpatrick P; Maguire A; Prencipe M; Brennan D; Doyle E; O'Grady A; Kay E; Furlong F; McCann A
    Hum Pathol; 2014 Jul; 45(7):1509-19. PubMed ID: 24792619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aurora kinases as prognostic biomarkers in ovarian carcinoma.
    Mendiola M; Barriuso J; Mariño-Enríquez A; Redondo A; Domínguez-Cáceres A; Hernández-Cortés G; Pérez-Fernández E; Sánchez-Navarro I; Vara JA; Suárez A; Espinosa E; González-Barón M; Palacios J; Hardisson D
    Hum Pathol; 2009 May; 40(5):631-8. PubMed ID: 19157502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.
    Faria AM; Almeida MQ
    Mol Cell Endocrinol; 2012 Mar; 351(1):52-7. PubMed ID: 22019901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZM447439, the Aurora kinase B inhibitor, suppresses the growth of cervical cancer SiHa cells and enhances the chemosensitivity to cisplatin.
    Zhang L; Zhang S
    J Obstet Gynaecol Res; 2011 Jun; 37(6):591-600. PubMed ID: 21159048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores.
    Ditchfield C; Johnson VL; Tighe A; Ellston R; Haworth C; Johnson T; Mortlock A; Keen N; Taylor SS
    J Cell Biol; 2003 Apr; 161(2):267-80. PubMed ID: 12719470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk marker.
    Yen CC; Yeh CN; Cheng CT; Jung SM; Huang SC; Chang TW; Jan YY; Tzeng CH; Chao TC; Chen YY; Yang CY; Ho CL; Fletcher JA
    Ann Surg Oncol; 2012 Oct; 19(11):3491-9. PubMed ID: 22588468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting aurora kinases as a potential prognostic and therapeutical biomarkers in pediatric acute lymphoblastic leukaemia.
    Moreira-Nunes CA; Mesquita FP; Portilho AJS; Mello Júnior FAR; Maués JHDS; Pantoja LDC; Wanderley AV; Khayat AS; Zuercher WJ; Montenegro RC; de Moraes-Filho MO; de Moraes MEA
    Sci Rep; 2020 Dec; 10(1):21272. PubMed ID: 33277547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma.
    Liu AW; Cai J; Zhao XL; Xu AM; Fu HQ; Nian H; Zhang SH
    J Clin Pathol; 2009 Nov; 62(11):1003-8. PubMed ID: 19861558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.
    Grabsch H; Takeno S; Parsons WJ; Pomjanski N; Boecking A; Gabbert HE; Mueller W
    J Pathol; 2003 May; 200(1):16-22. PubMed ID: 12692836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aurora kinase A is superior to Ki67 as a prognostic indicator of survival in neuroblastoma.
    Ramani P; Nash R; Rogers CA
    Histopathology; 2015 Feb; 66(3):370-9. PubMed ID: 25297850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High proliferation index, as determined by immunohistochemical expression of Aurora kinase B and geminin, indicates poor prognosis in neuroblastomas.
    Ramani P; Sowa-Avugrah E; May MT
    Virchows Arch; 2015 Sep; 467(3):319-27. PubMed ID: 26199132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes.
    Letouzé E; Rosati R; Komechen H; Doghman M; Marisa L; Flück C; de Krijger RR; van Noesel MM; Mas JC; Pianovski MA; Zambetti GP; Figueiredo BC; Lalli E
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1284-93. PubMed ID: 22539591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the
    Gong X; Du J; Parsons SH; Merzoug FF; Webster Y; Iversen PW; Chio LC; Van Horn RD; Lin X; Blosser W; Han B; Jin S; Yao S; Bian H; Ficklin C; Fan L; Kapoor A; Antonysamy S; Mc Nulty AM; Froning K; Manglicmot D; Pustilnik A; Weichert K; Wasserman SR; Dowless M; Marugán C; Baquero C; Lallena MJ; Eastman SW; Hui YH; Dieter MZ; Doman T; Chu S; Qian HR; Ye XS; Barda DA; Plowman GD; Reinhard C; Campbell RM; Henry JR; Buchanan SG
    Cancer Discov; 2019 Feb; 9(2):248-263. PubMed ID: 30373917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.
    Michalkiewicz E; Sandrini R; Figueiredo B; Miranda EC; Caran E; Oliveira-Filho AG; Marques R; Pianovski MA; Lacerda L; Cristofani LM; Jenkins J; Rodriguez-Galindo C; Ribeiro RC
    J Clin Oncol; 2004 Mar; 22(5):838-45. PubMed ID: 14990639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
    Hof J; Krentz S; van Schewick C; Körner G; Shalapour S; Rhein P; Karawajew L; Ludwig WD; Seeger K; Henze G; von Stackelberg A; Hagemeier C; Eckert C; Kirschner-Schwabe R
    J Clin Oncol; 2011 Aug; 29(23):3185-93. PubMed ID: 21747090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.